The agreement is set to draw political ire in a US presidential election year for Pfizer’s decision to use the transaction to redomicile in Ireland, where Allergan is registered, in a so-called “inversion,” thereby reducing its corporate tax rate.
Subscribe To Our Free Newsletter |